Showing 1 - 5 results of 5 for search 'M. Yu. Zubareva', query time: 0.01s Refine Results
  1. 1
    Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines

    Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the leve... by A. V. Susekov, M. Yu. Zubareva, T. A. Rozhkova, V. P. Masenko

    Published 2011-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia

    ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with in... by M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva, A. V. Susekov

    Published 2010-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis

    Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis by A. V. Susekov, N. B. Gornyakova, M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva

    Published 2009-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen levels

    Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen l... by A. V. Susekov, M. Yu. Zubareva, M. I. Tripoten’, T. A. Rozhkova, O. A. Pogorelova, T. V. Balakhonova, V. P. Masenko, V. V. Kukharchuk

    Published 2006-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Randomized study FARVATER: Part II. Atorvastatin effects on endothelial function, vascular wall distensibility and stiffness

    Randomized study FARVATER: Part II. Atorvastatin effects on endothelial function, vascular wall distensibility and stiffness by A. V. Susekov, T. A. Rozhkova, M. I. Tripoten’, O. A. Pogorelova, B. D. Kulev, T. V. Balakhonova, M. Yu. Zubareva, V. P. Masenko, A. N. Rogoza, V. V. Kukharchuk

    Published 2007-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: